KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,966,000 | -73.0% | 1,694,853 | -23.5% | 0.14% | -71.4% |
| Q2 2015 | $22,097,000 | -16.8% | 2,214,114 | +6.2% | 0.47% | -24.5% |
| Q1 2015 | $26,551,000 | +1.8% | 2,085,694 | +13.1% | 0.62% | -10.1% |
| Q4 2014 | $26,089,000 | +10.6% | 1,843,754 | +7.4% | 0.70% | -2.3% |
| Q3 2014 | $23,595,000 | +37.1% | 1,715,970 | +53.3% | 0.71% | +34.4% |
| Q2 2014 | $17,213,000 | +11.7% | 1,119,172 | +23.8% | 0.53% | -2.9% |
| Q1 2014 | $15,409,000 | +46.5% | 904,313 | +11.3% | 0.54% | +38.3% |
| Q4 2013 | $10,521,000 | – | 812,401 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |